Background & Aims The pathogenesis of immune checkpoint inhibitor (ICI)–colitis remains
incompletely understood. We sought to identify key cellular drivers of ICI-colitis and their …

Histoacryl glue is used increasingly for the treatment of gastric and ectopic varices, and there
is experience in its use for oesophageal varices. It is an effective treatment, yet numerous …

Although COVID-19 was first recognised as an acute respiratory illness, extra-pulmonary
manifestations are increasingly being recognised. Acute gastrointestinal side effects have been …

Objective Ustekinumab is an interleukin-12/interleukin-23 receptor antagonist licensed for
the treatment of ulcerative colitis (UC). Clinical trial data were promising; however, real-world …

Background and Aims Inflammatory bowel disease [IBD] is associated with high rates of post-colonoscopy
colorectal cancer [PCCRC], but further in-depth qualitative analyses are …

Background Anti‐tumour necrosis factor therapy is an established treatment for moderate‐to‐severely
active ulcerative colitis (UC). Recent network meta‐analyses of controlled trial …

Introduction Inflammatory Bowel Disease (IBD) services across the UK are under increasing
pressure. To improve efficiency, pathways of care have been proposed. However these are …

Introduction Faecal calprotectin (FCP) testing is useful in the assessment of patients with
inflammatory bowel disease (IBD). Home FCP testing bypasses the laboratory providing an …

Introduction Ustekinumab is an IL-12/23 receptor antagonist licensed for the treatment of
ulcerative colitis (UC). Clinical trial data were promising however real-world data are limited. …

Introduction Endoscopic assessment of ulcerative colitis (UC) plays a vital role in determining
the management of the disease. The British Society of Gastroenterology and European …